The wholly owned subsidiary will provide pharmaceutical sales teams with operational and human resources (HR) support.
The new business unit will expand Mission’s Northeastern US presence which also includes the company’s Commercial Group operations and BioComp Pharma, Mission’s lifecycle management and generics company.
Alamo will initially focus on those sales teams representing Mission’s four primary therapeutic areas, women’s health, urology, pediatrics, and the newly launched dermatology team.
Alamo Pharma president Terry Herring said that they are focused on providing added benefits through Mission’s strategic business partnerships with other pharmaceutical companies servicing similar therapeutic areas.
"These types of alliances are critically important to us and Alamo will work to both establish and enhance them moving forward," Herring added.